JAMES LEE to Treatment Outcome
This is a "connection" page, showing publications JAMES LEE has written about Treatment Outcome.
Connection Strength
0.122
-
Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population. J Pharm Pract. 2018 Apr; 31(2):150-156.
Score: 0.044
-
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Ann Intern Med. 2023 04; 176(4):515-523.
Score: 0.016
-
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. J Am Heart Assoc. 2022 02 15; 11(4):e024159.
Score: 0.015
-
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2021 03; 109(3):705-715.
Score: 0.014
-
Use of Direct Oral Anticoagulants in Morbidly Obese Patients. Pharmacotherapy. 2020 01; 40(1):72-83.
Score: 0.013
-
Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review. Ann Pharmacother. 2017 Dec; 51(12):1122-1137.
Score: 0.011
-
Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system. BMC Med Genomics. 2014; 7 Suppl 1:S13.
Score: 0.009